Guardant Health rated new Outperform at RBC (GH:NASDAQ)
· seekingalpha.com
Guardant Health (GH) stock gains as RBC Capital Markets initiates at Outperform with a $185 target, citing catalysts and pricing upside. Read more here.
RBC Capital Markets on Friday initiated Guardant Health (GH) with an Outperform recommendation, citing promising growth prospects and a catalyst-rich period for...